OXFD - Oxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kit

Oxford Immunotec (OXFD) announces it has worked with Green Cross Medical Science South Korea (GC MS) to enter into an MOU to market the research use only T-SPOT Discovery SARS-CoV-2 kit in South Korea.Under the agreement, GC MS will market and sell the product with Oxford Immunotec Korea providing overall support for the T-SPOT Discovery SARS-CoV-2 kit.GC MS is an industry leader in the field of medical devices and diagnostic reagents, and a member of the GC Pharmaceutical companies, in South Korea.Oxford had recently announces an update to the configuration of its T-SPOT Discovery SARS-CoV-2 kit to include a cross-reactive panel, earlier this month.

For further details see:

Oxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kit